Hamilton Lane Advisors’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

Hamilton Lane Advisors’s Portfolio KYTH Stock Details KYTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-24,625	Closed	-$1.85M	–	69
2015 Q3	$1.85M	Buy	+24,625	New	+$1.84M	0.91%	26
2014 Q2	–	Sell	-30,264	Closed	-$1.2M	–	77
2014 Q1	$1.2M	Buy	+30,264	New	+$1.35M	0.48%	41

Hamilton Lane Advisors's KYTH Position: Q4 2015 in Review

Hamilton Lane Advisors sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q4 2015, closing a stake of 24,625 shares — an estimated $1.85M sold.

Hamilton Lane Advisors first reported a position in KYTH in Q1 2014 and held it in 2 quarters. The position peaked at $1.85M in Q3 2015. 0 funds tracked by Wall St. Rank hold KYTH as of Q4 2015.

Hamilton Lane Advisors reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q4 2015 after selling out during the quarter.
Hamilton Lane Advisors sold 24,625 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q4 2015, an estimated $1.85M.
Hamilton Lane Advisors first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q1 2014 and held it in 2 quarters.
Hamilton Lane Advisors's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $1.85M in Q3 2015.
0 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q4 2015.

Based on Hamilton Lane Advisors's 13F filing for Q4 2015, filed 22 Jan 2016.